CCEL vs ESS · P/E 490, $39.6M cap vs P/E 31, rev $1.89B
CryoCell International Inc (CCEL) versus Essex Property Trust Inc (ESS) — a side-by-side from cached financials, not a winner call.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
CCEL does not have a complete income-statement cache yet.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
CCEL currently screens at market cap $39.6M and trailing P/E 490.0. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Not investment advice. Open the CCEL and ESS stock pages for the full models.
Not investment advice.